Stay updated on CV301-Nivolumab Combo in Metastatic CRC Clinical Trial

Sign up to get notified when there's something new on the CV301-Nivolumab Combo in Metastatic CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CV301-Nivolumab Combo in Metastatic CRC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision updated to v3.0.2; the previous v3.0.1 revision tag and the 'Back to Top' element were removed.
    Difference
    0.1%
    Check dated 2025-09-14T09:54:48.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.1%
    Check dated 2025-09-07T07:52:02.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as detailed information on various medical topics such as colorectal cancer and specific vaccines. Notably, the revision number has been updated to v3.0.0.
    Difference
    2%
    Check dated 2025-08-31T00:58:10.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T20:01:08.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been significantly updated to include extensive details about a clinical trial, including information on study design, eligibility criteria, and treatment protocols. Key entities such as the U.S. Food and Drug Administration (FDA) and the U.S. Agency for Healthcare Research and Quality (AHRQ) have been mentioned, enhancing the credibility and context of the study.
    Difference
    100%
    Check dated 2025-08-09T15:24:54.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The web page has removed a significant service alert regarding planned maintenance that would affect service availability for over 24 hours, as well as various details about a clinical trial for metastatic colorectal cancer, including study design, eligibility criteria, and treatment protocols.
    Difference
    99%
    Check dated 2025-07-26T12:25:46.000Z thumbnail image

Stay in the know with updates to CV301-Nivolumab Combo in Metastatic CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CV301-Nivolumab Combo in Metastatic CRC Clinical Trial page.